214 related articles for article (PubMed ID: 9499041)
21. Down regulation of human immunodeficiency virus type-1 (HIV-1) expression by Vif antisense RNA expression vectors in transfected cells.
Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Kobayashi H; Ishikawa K; Osei-Kwasi M; Ampofo WK; Ofori-Adjei D; Inagaki Y; Yamamoto N; Takaku H
Nucleic Acids Res Suppl; 2002; (2):123-4. PubMed ID: 12903136
[TBL] [Abstract][Full Text] [Related]
22. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
24. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HIV-1 replication by RNA targeted against the LTR region.
Puerta-Fernández E; Barroso-del Jesus A; Romero-López C; Tapia N; Martínez MA; Berzal-Herranz A
AIDS; 2005 Jun; 19(9):863-70. PubMed ID: 15905666
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region.
Renneisen K; Leserman L; Matthes E; Schröder HC; Müller WE
J Biol Chem; 1990 Sep; 265(27):16337-42. PubMed ID: 1697856
[TBL] [Abstract][Full Text] [Related]
27. HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period.
Kobayashi-Ishihara M; Yamagishi M; Hara T; Matsuda Y; Takahashi R; Miyake A; Nakano K; Yamochi T; Ishida T; Watanabe T
Retrovirology; 2012 May; 9():38. PubMed ID: 22569184
[TBL] [Abstract][Full Text] [Related]
28. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Kim JH; McLinden RJ; Mosca JD; Vahey MT; Greene WC; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):343-51. PubMed ID: 8673542
[TBL] [Abstract][Full Text] [Related]
30. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
Zhou C; Bahner I; Rossi JJ; Kohn DB
Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
32. Antiviral potency of drug-gene therapy combinations against human immunodeficiency virus type 1.
Junker U; Baker J; Kalfoglou CS; Veres G; Kaneshima H; Böhnlein E
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1395-402. PubMed ID: 9359659
[TBL] [Abstract][Full Text] [Related]
33. Reduction in replication of the human immunodeficiency virus type 1 in human T cell lines by polymerase III-driven transcription of chimeric tRNA-antisense RNA genes.
Junker U; Rittner K; Homann M; Bevec D; Böhnlein E; Sczakiel G
Antisense Res Dev; 1994; 4(3):165-72. PubMed ID: 7849487
[TBL] [Abstract][Full Text] [Related]
34. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.
Bonyhadi ML; Moss K; Voytovich A; Auten J; Kalfoglou C; Plavec I; Forestell S; Su L; Böhnlein E; Kaneshima H
J Virol; 1997 Jun; 71(6):4707-16. PubMed ID: 9151864
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.
VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA
J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
38. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference.
Park WS; Miyano-Kurosaki N; Hayafune M; Nakajima E; Matsuzaki T; Shimada F; Takaku H
Nucleic Acids Res; 2002 Nov; 30(22):4830-5. PubMed ID: 12433985
[TBL] [Abstract][Full Text] [Related]
39. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.
Homann M; Rittner K; Sczakiel G
J Mol Biol; 1993 Sep; 233(1):7-15. PubMed ID: 8377194
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
